Antibodies against endogenous retroviruses
2024

Antibodies Against Endogenous Retroviruses

publication Evidence: moderate

Author Information

Author(s): Chisca Mihaela, Larouche Jean‐David, Xing Qi, Kassiotis George

Primary Institution: The Francis Crick Institute

Hypothesis

The study investigates the immunogenicity of endogenous retroviruses (ERVs) and their potential role in various diseases.

Conclusion

The presence of antibodies against ERV antigens is linked to a variety of diseases, including cancer and autoimmune disorders, suggesting a complex role in immune responses.

Supporting Evidence

  • ERVs are remnants of ancient viruses that can trigger immune responses.
  • Antibodies against ERV proteins have been found in various autoimmune and cancer conditions.
  • The immunogenicity of ERV proteins may vary depending on the disease context.

Takeaway

Our bodies have old virus parts that can sometimes confuse our immune system, making it think there's an infection, which can lead to diseases.

Methodology

The review summarizes existing studies on the antibody responses to ERV proteins in various diseases.

Limitations

The precise mechanisms and effects of ERV antibodies in disease contexts are still not fully understood.

Digital Object Identifier (DOI)

10.1111/imr.13378

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication